{"id":659879,"date":"2025-04-01T11:35:12","date_gmt":"2025-04-01T08:35:12","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/alphabets-ai-drug-discovery-platform-isomorphic-labs-raises-600m-from-thrive\/"},"modified":"2025-04-01T11:35:12","modified_gmt":"2025-04-01T08:35:12","slug":"alphabets-ai-drug-discovery-platform-isomorphic-labs-raises-600m-from-thrive","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/alphabets-ai-drug-discovery-platform-isomorphic-labs-raises-600m-from-thrive\/","title":{"rendered":"Alphabet&#8217;s AI drug discovery platform Isomorphic Labs raises $600M from Thrive"},"content":{"rendered":"<div>\n<p id=\"speakable-summary\" class=\"wp-block-paragraph\">Isomorphic Labs, the AI drug-discovery platform that was spun out of Google\u2019s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with participation from GV and existing investor Alphabet, Google\u2019s parent, <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/www.isomorphiclabs.com\/articles\/isomorphic-labs-announces-600m-external-investment-round\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">it said<\/a>. \u00a0\u00a0\u00a0<\/p>\n<p class=\"wp-block-paragraph\">The funding will accelerate further development of Isomorphic\u2019s AI drug design engine and support the company\u2019s goal of bringing its discovered drugs to clinical trials.<\/p>\n<p class=\"wp-block-paragraph\">Isomorphic Labs was founded by DeepMind co-founder Demis Hassabis by leveraging DeepMind\u2019s software for AI drug discovery, including AlphaFold, an AI model that predicts the three-dimensional structures of proteins.<\/p>\n<p class=\"wp-block-paragraph\">Last year, Isomorphic Labs secured strategic partnerships with Eli Lilly and Novartis, potentially generating up to $3 billion in milestone payments for access to its AI model.<\/p>\n<p class=\"wp-block-paragraph\">Hassabis told <a rel=\"nofollow\" target=\"_blank\" target=\"_blank\" href=\"https:\/\/www.nytimes.com\/2025\/03\/31\/business\/dealbook\/isomorphic-google-thrive-investment.html\" rel=\"noreferrer noopener nofollow\">the New York Times<\/a> that while Isomorphic Labs didn\u2019t need the capital, the extra funding will help the division hire top research scientists.<\/p>\n<p class=\"wp-block-paragraph\">For their work on AlphaFold, Hassabis and DeepMind researcher John Jumper were among the three scientists who received a <a rel=\"nofollow\" target=\"_blank\" href=\"https:\/\/www.nobelprize.org\/prizes\/chemistry\/2024\/press-release\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Nobel Prize in chemistry<\/a> in 2024.<\/p>\n<\/div>\n<blockquote><p><strong><span style=\"color: #ff6600;\">If you liked the article, do not forget to share it with your friends. Follow us on\u00a0<span style=\"color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN63nwsw68G3Aw\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more like this article, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/category\/technology\/\" target=\"_blank\" >Technology<\/a><\/span> category.<\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/techcrunch.com\/2025\/03\/31\/alphabets-ai-drug-discovery-platform-isomorphic-labs-raises-600m-from-thrive\/\" target=\"_blank\" >Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Isomorphic Labs, the AI drug-discovery platform that was spun out of Google\u2019s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with participation from GV and existing investor Alphabet, Google\u2019s parent, it said. \u00a0\u00a0\u00a0 The funding will accelerate further development of Isomorphic\u2019s AI drug&#8230;<\/p>\n","protected":false},"author":1,"featured_media":659880,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/techcrunch.com\/wp-content\/uploads\/2016\/07\/gettyimages-450853983.jpg?resize=1200,800","fifu_image_alt":"","footnotes":""},"categories":[18],"tags":[77337,151734,90378,151516,153076,151418,155252,151477],"class_list":["post-659879","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-ai","tag-ai-drug-discovery","tag-alphabet","tag-biotech-health","tag-deepmind","tag-in-brief","tag-isomorphic-labs","tag-venture"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/659879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=659879"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/659879\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/659880"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=659879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=659879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=659879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}